Pharmacological mechanism of thalidomide and its research progress in inflammatory bowel disease
10.13699/j.cnki.1001-6821.2018.03.061
- VernacularTitle:沙利度胺的药理学机制及其在炎症性肠病中的研究现状
- Author:
Jun LI
1
;
Lei MAO
;
Xue-Ting ZHOU
;
Li-Ping GAO
;
Jin-Yong HAO
;
Jie-Qiong HU
;
Xiang WANG
Author Information
1. 兰州大学第二临床医学院
- Keywords:
thalidomide;
inflammatory bowel disease;
cytokine
- From:
The Chinese Journal of Clinical Pharmacology
2018;34(3):387-389
- CountryChina
- Language:Chinese
-
Abstract:
Thalidomide is widely used in the treatment of inflammatory diseases with its anti-inflammatory,anti-angiogenic and immunomodulatory properties,and it has been included in the studies for treating inflammatory bowel disease in recent years,but still in the period of exploration.In this paper,the pharmacological mechanism of thalidomide and its research progress in inflammatory bowel disease are reviewed in order to provide a better guide for follow-up studies.
